ADDEX PHARMACEUTICALS | 6,727 Euro | +0,427 +6,78 % | |
| WKN: A0MSH6 ISIN: CH0029850754 Ticker-Symbol: APE | Frankfurt | 25.05.12 | 18:14 Uhr |
Branche PharmaAktienmarkt Sonstige |
|
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 09.05. | Addex Therapeutics: Addex Shareholders Approve All Board Proposals at Annual General Meeting | 36 | Thomson Reuters ONE | |
| Addex Therapeutics /
Addex Shareholders Approve All Board Proposals at Annual General Meeting
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of... Mehr lesen zu: Addex Therapeutics: Addex Shareholders Approve All Board Proposals at Annual General Meeting | ||||
| 16.04. | Addex Therapeutics: Addex Reports Positive Preclinical Data for GABA-BR PAM Oral Small Molecule in Overactive Bladder | 64 | Thomson Reuters ONE | |
| Addex Therapeutics /
Addex Reports Positive Preclinical Data for GABA-BR PAM Oral Small Molecule in
Overactive Bladder
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible... Mehr lesen zu: Addex Therapeutics: Addex Reports Positive Preclinical Data for GABA-BR PAM Oral Small Molecule in Overactive Bladder | ||||
| 13.04. | Stellenabbau beim Pharmaunternehmen Addex | 7 | Handelszeitung | |
| 13.04. | Addex Therapeutics: Addex Takes Steps to Rightsize Operations and Position the Company for Future Success | 97 | Thomson Reuters ONE | |
| Addex Therapeutics /
Addex Takes Steps to Rightsize Operations and Position the Company for Future
Success
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for... Mehr lesen zu: Addex Therapeutics: Addex Takes Steps to Rightsize Operations and Position the Company for Future Success | ||||
| 22.03. | Addex: Positive Phase IIa-Studie mit Dipraglurant | 103 | Moneycab | |
| Addex-CEO Bharatt Chowrira. Plan-les-Ouates - Das Pharma-Unternehmen Addex meldet positive Ergebnisse einer klinischen Studie der Phase IIa mit Dipraglurant zur Behandlung levodopainduzierter Dyskinesien... Mehr lesen zu: Addex: Positive Phase IIa-Studie mit Dipraglurant | ||||
| 21.03. | Addex Therapeutics: Addex Reports Positive Top Line Phase IIa Data for Dipraglurant in Parkinson's Disease Levodopa-Induced Dyskinesia (PD-LID) | 52 | Thomson Reuters ONE | |
| Addex Therapeutics /
Addex Reports Positive Top Line Phase IIa Data for Dipraglurant in Parkinson's
Disease Levodopa-Induced Dyskinesia (PD-LID)
. Processed and transmitted by Thomson Reuters ONE.
The... Mehr lesen zu: Addex Therapeutics: Addex Reports Positive Top Line Phase IIa Data for Dipraglurant in Parkinson's Disease Levodopa-Induced Dyskinesia (PD-LID) | ||||
| 21.03. | Addex Pharmaceuticals: Addex Changes Name to Addex Therapeutics, Launches New Website and Corporate Branding | 48 | Thomson Reuters ONE | |
| Addex Pharmaceuticals /
Addex Changes Name to Addex Therapeutics, Launches New Website and Corporate
Branding
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for... Mehr lesen zu: Addex Pharmaceuticals: Addex Changes Name to Addex Therapeutics, Launches New Website and Corporate Branding | ||||
| 23.02. | Addex weiter mit Verlusten | 66 | BörseGo | |
| Genf (Godmode-Trader.ch) - Der Umsatz von Addex Pharmaceuticals ist im Geschäftsjahr 2011 auf 3,7 Millionen Schweizer Franken gesunken. Darin enthalten ist eine Meilensteinzahlung in Höhe von 2,6 Millionen... Mehr lesen zu: Addex weiter mit Verlusten | ||||
| 23.02. | Addex Pharmaceuticals: Addex Pharmaceuticals Reports 2011 Financial Results | 66 | Thomson Reuters ONE | |
| Addex Pharmaceuticals /
Addex Pharmaceuticals Reports 2011 Financial Results
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.... Mehr lesen zu: Addex Pharmaceuticals: Addex Pharmaceuticals Reports 2011 Financial Results | ||||
| 21.02. | Addex Pharmaceuticals: Addex Pharmaceuticals 2011 Financial Results This Thursday | 33 | Thomson Reuters ONE | |
| Addex Pharmaceuticals /
Addex Pharmaceuticals 2011 Financial Results This Thursday
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.... Mehr lesen zu: Addex Pharmaceuticals: Addex Pharmaceuticals 2011 Financial Results This Thursday | ||||
| 10.02. | Addex Pharmaceuticals: Addex to Present at the BIO CEO & Investor Conference | 65 | Thomson Reuters ONE | |
| Addex Pharmaceuticals /
Addex to Present at the BIO CEO & Investor Conference
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.... Mehr lesen zu: Addex Pharmaceuticals: Addex to Present at the BIO CEO & Investor Conference | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| SANTHERA PHARMACEUTICALS | 3,510 | -6,30 % | Santhera Pharmaceuticals Holding AG: Santhera Shareholders Approve all Board Proposals at Annual Shareholders' Meeting |
| NOVARTIS AG | 41,600 | +0,63 % | Novartis-Präsident Vasella kritisiert die Einwanderungspolitik |
| BIOMARIN PHARMACEUTICAL | 30,720 | +1,17 % | BioMarin Appoints Dan Spiegelman As CFO |
| AMARIN CORPORATION | 8,707 | +6,81 % | Amarin Crosses Above its 10-day MA |
| GERRESHEIMER AG | 35,215 | +1,63 % | DGAP-Stimmrechte: Gerresheimer AG (deutsch) |
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
